These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15196794)

  • 21. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
    O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
    Suemaru J; Akiyama K; Tanabe Y; Kuroda S
    Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a role of CaMKIV in the development of opioid analgesic tolerance.
    Ko SW; Jia Y; Xu H; Yim SJ; Jang DH; Lee YS; Zhao MG; Toyoda H; Wu LJ; Chatila T; Kaang BK; Zhuo M
    Eur J Neurosci; 2006 Apr; 23(8):2158-68. PubMed ID: 16630062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
    Mamiya T; Matsumura T; Ukai M
    Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
    González-Cuello A; Milanés MV; Castells MT; Laorden ML
    Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agrin signaling in cortical neurons is mediated by a tyrosine kinase-dependent increase in intracellular Ca2+ that engages both CaMKII and MAPK signal pathways.
    Hilgenberg LG; Smith MA
    J Neurobiol; 2004 Dec; 61(3):289-300. PubMed ID: 15389602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
    Verma A; Kulkarni SK
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):81-7. PubMed ID: 7549459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
    Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
    J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible involvement of the hypothalamic pro-opiomelanocortin gene and beta-endorphin expression on acute morphine withdrawal development.
    Seo YJ; Kwon MS; Choi SM; Lee JK; Park SH; Jung JS; Sim YB; Suh HW
    Brain Res Bull; 2009 Dec; 80(6):359-70. PubMed ID: 19723567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of morphine antinociceptive tolerance and dependence by the acute supraspinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II.
    Tang L; Shukla PK; Wang LX; Wang ZJ
    J Pharmacol Exp Ther; 2006 May; 317(2):901-9. PubMed ID: 16505162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats.
    Tai YH; Wang YH; Wang JJ; Tao PL; Tung CS; Wong CS
    Pain; 2006 Sep; 124(1-2):77-86. PubMed ID: 16697108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal.
    Nunez C; Földes A; Laorden ML; Milanes MV; Kovács KJ
    J Neurochem; 2007 May; 101(4):1060-71. PubMed ID: 17286593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonistic effects of methanolic extract of Polygala telephioides on morphine responses in mice.
    Egashira N; Li JC; Mizuki A; Yamauchi K; Matsuda T; Osajima M; Matsushita M; Mishima K; Iwasaki K; Hara S; Ono N; Nishimura R; Nohara T; Fujiwara M
    J Ethnopharmacol; 2006 Mar; 104(1-2):193-8. PubMed ID: 16202547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
    Medvedev IO; Dravolina OA; Bespalov AY
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
    Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
    Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
    Cao JL; Liu HL; Wang JK; Zeng YM
    Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.